• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

I Ahrens, GYH Lip, K Peter

Thrombosis and Haemostasis | GEORG THIEME VERLAG KG | Published : 2011

DOI: 10.1160/TH10-12-0808

University of Melbourne Researchers

Karlheinz Peter's Profile Picture
Karlheinz Peter Author

Citation metrics

68Scopus
54Web of Science
60Dimensions

Keywords

Warfarin
Safety
Life Sciences & Biomedicine
Clinical Research
Brain Disorders
Peripheral Vascular Disease
Science & Technology
Inhibitor
Prevention
32 Biomedical and Clinical Sciences
Heart Disease
Rationale
3202 Clinical Sciences
Hematology
3201 Cardiovascular Medicine and Haematology
Cardiovascular System & Cardiology
Clinical Trials and Supportive Activities
Cerebrovascular
Efficacy
Cardiovascular
Apixaban
Design
Neurosciences

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224